PHARMACEUTICAL INNOVATION BY THE 7 UK-OWNED PHARMACEUTICAL COMPANIES (1964-1985)

被引：356
|
作者：
PRENTIS, RA
LIS, Y
WALKER, SR
机构：
来源：
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY | 1988年 / 25卷 / 03期
关键词：
D O I：
10.1111/j.1365-2125.1988.tb03318.x
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：387 / 396
页数：10
相关论文
共 50 条
  • [21] Competition and Pharmaceutical Innovation: The Moderating Role of Size and Age of Leading Companies in the Market
    Jung, Ye Lim
    Yoo, Hyoung Sun
    IEEE TRANSACTIONS ON ENGINEERING MANAGEMENT, 2024, 71 : 3088 - 3097
  • [22] Government innovation subsidy, executives' academic capital and innovation quality: Evidence from pharmaceutical companies in China
    Xia, Yuntian
    Fan, Min
    Zuo, Xu
    Hao, Wenjing
    Jia, Yiwen
    FRONTIERS IN PSYCHOLOGY, 2023, 13
  • [23] Interaction between companies and institutions of Science and Technology - the case of the brazilian innovation pharmaceutical system
    Rapini, Marcia Siqueira
    REVISTA BRASILEIRA DE INOVACAO, 2014, 13 (01): : 225 - 230
  • [24] Enhancing organisational innovation capability-A practice-oriented insight for pharmaceutical companies
    Robb, Anna
    Rohrschneider, Marc
    Booth, Alex
    Carter, Peggy
    Walker, Richard
    Andrews, Georgina
    TECHNOVATION, 2022, 115
  • [25] THE GOOD PRACTICES OF CLEANER PRODUCTION IN THE BRAZILIAN PHARMACEUTICAL INDUSTRY COMPANIES: THE CONTRIBUTES OF THE OPEN INNOVATION
    Smalci, Anderson
    Silva, Orlando Roque
    REVISTA METROPOLITANA DE SUSTENTABILIDADE, 2019, 9 (03): : 6 - 20
  • [26] Autarkic drug discovery in Japanese pharmaceutical companies: insights into national differences in industrial innovation
    Kneller, R
    RESEARCH POLICY, 2003, 32 (10) : 1805 - 1827
  • [27] How Labor Costs Affect Innovation Output in Pharmaceutical Companies: Evidence from China
    Chen, Ying
    He, Qiankun
    Wang, Ting
    INQUIRY-THE JOURNAL OF HEALTH CARE ORGANIZATION PROVISION AND FINANCING, 2024, 61
  • [28] Contribution of Pharmaceutical Innovation to Longevity Growth in Germany and France, 2001–7
    Frank R. Lichtenberg
    PharmacoEconomics, 2012, 30 : 197 - 211
  • [29] Study on Innovation Behavior of State-owned Pharmaceutical Enterprises Based on the Viewpoint of Ownership Structure Reforming
    Shi, Shengyi
    Wang, Guangping
    Huo, Yanfei
    Yi, Baxian
    Wu, Xiaoming
    JOURNAL OF POLITICS AND LAW, 2016, 9 (09) : 195 - 204
  • [30] UK Pharmaceutical Companies Collaborate on CAR-T Cell Immuno-oncology Therapies
    不详
    BIOPHARM INTERNATIONAL, 2016, 29 (01) : 57 - 57
12345